tiprankstipranks
Atlantic International (ATLN)
NASDAQ:ATLN
US Market

Atlantic International (ATLN) Price & Analysis

Compare
40 Followers

ATLN Stock Chart & Stats

$4.45
$0.18(3.08%)
At close: 4:00 PM EST
$4.45
$0.18(3.08%)

Bulls Say, Bears Say

Bulls Say
Acquisition-driven Global ScaleThe all-stock acquisition of Circle8 creates a combined ~ $1.2B unaudited revenue platform and broadens geographic reach into Europe. This materially diversifies revenue and client coverage, enabling scale economics, cross-selling and structural revenue stability over the medium term.
Strong Revenue GrowthSustained TTM revenue growth (~52%) demonstrates robust demand across Atlantic’s telecom, logistics and renewable segments. Persistent top-line momentum supports investment in infrastructure and product development, improving the potential to leverage fixed costs and capture durable operating leverage.
Improving Cash GenerationModest positive FCF growth and FCF nearly matching net income indicate improving cash generation discipline. Over months, this enhances liquidity for integration, capex and debt service, reducing reliance on external funding and supporting more sustainable capital allocation despite current losses.
Bears Say
Negative Profitability / Low MarginsPersistent negative profitability and a low gross margin (~10.85%) signal weak pricing power or high input costs across core businesses. Continued margins pressure limits internal reinvestment, lengthens payback on acquisitions and complicates the path to sustainable operating profitability over the medium term.
Weak Balance Sheet / Negative EquityNegative shareholders' equity and a negative debt-to-equity ratio reflect a strained capital structure and elevated leverage. This increases refinancing and solvency risk, reduces strategic flexibility for capital spending or M&A, and could force dilutive financing actions if losses persist.
Poor Operating Cash ConversionA low operating cash flow to net income ratio indicates the business struggles to convert reported earnings into sustainable cash. This weak cash conversion undermines internal funding for operations and integration, raising the likelihood of continued dependence on external financing in the medium term.

Atlantic International News

ATLN FAQ

What was Atlantic International’s price range in the past 12 months?
Atlantic International lowest stock price was $1.16 and its highest was $5.65 in the past 12 months.
    What is Atlantic International’s market cap?
    Atlantic International’s market cap is $216.01M.
      When is Atlantic International’s upcoming earnings report date?
      Atlantic International’s upcoming earnings report date is Mar 26, 2026 which is today.
        How were Atlantic International’s earnings last quarter?
        Currently, no data Available
        Is Atlantic International overvalued?
        According to Wall Street analysts Atlantic International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Atlantic International pay dividends?
          Atlantic International does not currently pay dividends.
          What is Atlantic International’s EPS estimate?
          Atlantic International’s EPS estimate is -0.2.
            How many shares outstanding does Atlantic International have?
            Atlantic International has 62,611,656 shares outstanding.
              What happened to Atlantic International’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Atlantic International?
              Currently, no hedge funds are holding shares in ATLN
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Atlantic International Stock Smart Score

                6
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Company Description

                Atlantic International

                As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.

                Atlantic International (ATLN) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Aclaris Therapeutics
                MDxHealth
                Neuronetics
                Exagen
                Prenetics Group

                Ownership Overview

                31.64%0.86%66.89%
                31.64% Insiders
                ― Other Institutional Investors
                66.89% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks